Stay updated on Vatiquinone for Mitochondrial Disease and Refractory Epilepsy Clinical Trial

Sign up to get notified when there's something new on the Vatiquinone for Mitochondrial Disease and Refractory Epilepsy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Vatiquinone for Mitochondrial Disease and Refractory Epilepsy Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    New study record dates added: 2026-03-31 and 2026-03-29; dates 2026-03-25 and 2026-03-04 were removed.
    Difference
    0.3%
    Check dated 2026-04-04T06:15:55.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Added posted results for multiple seizure-related outcomes (e.g., percent change in motor seizures, total seizures, hospitalizations, seizure clusters) across time points up to Week 72, and removed several previously reported outcomes.
    Difference
    5%
    Check dated 2026-03-28T03:45:33.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Site-wide version update from v3.4.3 to v3.5.0; no study details or user-facing content appear to be modified.
    Difference
    0.2%
    Check dated 2026-03-21T01:16:28.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Updated view shows cosmetic UI and layout adjustments (header styling and spacing). Core study data such as enrollment, eligibility criteria, outcomes, and status appear unchanged.
    Difference
    0.2%
    Check dated 2026-03-13T20:20:13.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The page now shows 'Results Submitted' replacing 'No Results Posted,' and the revision is updated to v3.4.3.
    Difference
    0.3%
    Check dated 2026-03-06T18:39:56.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The study record now shows a Terminated Sponsor decision banner, indicating the trial has been terminated. This update changes the status of the study and informs potential participants and investigators about its closure.
    Difference
    0.2%
    Check dated 2026-02-27T18:56:43.000Z thumbnail image

Stay in the know with updates to Vatiquinone for Mitochondrial Disease and Refractory Epilepsy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Vatiquinone for Mitochondrial Disease and Refractory Epilepsy Clinical Trial page.